IDT Australia rises on MoU with US-based drug-delivery platform
** Shares of IDT Australia IDT.AX rise as much as nearly 16% to A$0.11, their highest level since June 10 ** Stock last up about 5% ** Pharma company signs MoU with U.S.-based Gelteq GELS.O to set up manufacturing unit in Australia ** Trading volume at around 277,900 shares, 2x 30-day avg ** Session trims YTD losses to 9% (Reporting by Shruti Agarwal in Bengaluru) ((Shruti.Agarwal@thomsonreuters.com))
Recent news on IDT Australia
See all newsBrief: IDT Australia Sees Unaudited Fy26 Revenue From Three Verticals To Rise To A$16.8 Million
IDT Australia soars on upgraded annual earnings forecasts
IDT Australia climbs on positive FY26 outlook
Brief: Idt Australia Forecasts FY26 EBITDA Loss Of A$1.5m-A$2m
IDT Australia eyes strongest session in over four years as EBITDA loss narrows